US FDA Searches For Consistency On Assessment Of Real-World Evidence

As more sponsors begin using RWE, the agency is establishing procedures and training to ensure assessors consistently apply policies.

Archery
The US FDA is employing a similar approach to ensure assessor consistency as it did with rare diseases.

The US Food and Drug Administration may be leading efforts to increase use of real-world evidence, but also expects its own staff will need further education on the subject.

An internal FDA committee is ensuring applications including real-world evidence are handled the same way throughout the review divisions. Jacqueline...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Approval Standards

More from Pathways & Standards